ArticleMolecular psychiatry2026
Mapping the psychosis spectrum - imaging neurosubtypes from multiscale functional network connectivity.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Psychosis exhibits marked neurobiological heterogeneity that is not adequately captured by symptom-based diagnoses. Although prior efforts have identified subgroups, it remains unclear how latent disease variability manifests within the brain's multiscale intrinsic functional organization and whether these patterns can be leveraged to systematically identify biologically driven subtypes of psychosis. Here, we aim to identify Psychosis Imaging Neurosubtypes (PINs)-homogeneous subgroups defined solely from neurobiological features of brain function, independent of clinical or cognitive definitions, and whether these subgroups show meaningful phenotypic differentiation. Resting-state fMRI data from 2103 B-SNIP 1&2 participants were used to compute subject-specific multiscale functional network connectivity (msFNC). We then derived a low-dimensional neurobiological subspace, termed Latent Network Connectivity, which captured system-wide interconnected multiscale information across three components. Projections of probands msFNC onto this subspace revealed three PINs through unsupervised learning that spanned DSM diagnoses (Schizophrenia, Bipolar, Schizoaffective Disorder). Although defined purely from intrinsic neurobiology, PINs exhibited distinct cognitive, clinical, and connectivity profiles. PIN-1, the most cognitively impaired, showed Cerebellar-Subcortical and Visual-Sensorimotor hypoconnectivity, alongside Visual-Subcortical hyperconnectivity. Most cognitively preserved PIN-2 showed Visual-Subcortical, Subcortical-Sensorimotor, and Subcortical-Higher Cognition hypoconnectivity. PIN-3 exhibited intermediate cognition, showing Cerebellar-Subcortical hypoconnectivity alongside Cerebellar-Sensorimotor and Subcortical-Sensorimotor hyperconnectivity. Although covariate-adjusted analyses did not reveal significant clinical differences among PINs, exploratory analyses identified selective differences in YMDR, PANSS, and Age of Onset. Notably, 55% of relatives aligned with the same neurosubtype as their probands, a rate significantly higher than chance and than DSM-based alignment, suggesting potential heritability. Cognitive performance reliably aligns with distinct brain connectivity patterns, which are also evident in relatives, supporting their construct validity. Our PINs partially converged with previously reported BSNIP Biotypes with some correspondence (e.g. PIN1 with Biotype 1) but not with the other Biotypes, which were determined using integrated electrophysiological, cognitive, and oculomotor data, supporting convergent validity, while also indicating that intrinsic rsfMRI derived multiscale connectivity partitions psychosis heterogeneity somewhat differently from multimodal biomarker approaches. These findings underscore the limitations of DSM-based classifications in capturing the biological complexity of psychotic disorders and highlight the potential of imaging-based neurosubtypes to enhance our understanding of the psychosis spectrum.
Identifiers
42855456What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.